Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galvus as add-on to insulin in type 2 diabetes mellitus
NCT01582230Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2012
- Primary completion
- May 2013
- Countries
- 4
01
Overview
A Phase 3 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Apr 2012; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01582230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01582230.